Trial · NCT02737475
Results by group2,200
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 2,200
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 1: BMS 20 mg Q2W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 1: BMS 40 mg Q2W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 1: BMS 80 mg Q2W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 1: BMS 160 mg Q2W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 1: BMS 320 mg Q2W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 2 BMS 20 mg + Nivo 240 mg Q2W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 2: BMS 40 mg + Nivo 240 mg Q2W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 2: BMS 80 mg + Nivo 240 mg Q2W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 2: BMS 160 mg + Nivo 240 mg Q2W | 1 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 2: BMS 320 mg + Nivo 240 mg Q2W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 3: BMS 20 mg + Ipi 1 mg/kg Q3W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 3: BMS 40 mg + Ipi 1 mg/kg Q3W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 3: BMS 80 mg + Ipi 1 mg/kg Q3W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 3: BMS 160 mg + Ipi 1 mg/kg Q3W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Escalation Part 3: BMS 320 mg + Ipi 1 mg/kg Q3W | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Expansion Part 2C: BMS 80 mg + Nivo 240 mg Q2W (BDC) | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Schedule and Dose Exploration Part 4: BMS 80 mg + Nivo 480 mg Q4W | 1 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Schedule and Dose Exploration Part 5: BMS 80 mg + Ipi 3 mg/kg Q3W | 1 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Safety Part 6A: BMS 40 mg + Nivo 240 mg + Ipi 1 mg/kg Q3W / BMS 40 mg + Nivo 480 mg Q4W (RCC) | 0 | Participants | ||
| The Number of Participants Experiencing Dose-Limiting Toxicities (DLTs) | Expansion Part 6B: BMS 40 mg + Nivo 240 mg + Ipi 1 mg/kg Q3W / BMS 40 mg + Nivo 480 mg Q4W (RCC) | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02737475/results